if what Dr. Richard Pazdur, head of FDA's Office of Oncology Drug Products, is as good as his word..."Efficacy, efficacy, efficacy. That's what we're looking for....Believe me, if there were a clear survival effect the drug would be approved." Pazdur is the Czar.
Market Data 
Markets 
AI
